Avinger Inc (NASDAQ:AVGR) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $0.27 and last traded at $0.29, with a volume of 898900 shares. The stock had previously closed at $0.34.

Separately, Zacks Investment Research lowered shares of Avinger from a “hold” rating to a “sell” rating in a report on Friday, August 17th.

Avinger (NASDAQ:AVGR) last released its earnings results on Monday, August 13th. The medical device company reported ($0.98) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.48) by ($0.50). The firm had revenue of $2.06 million for the quarter. Sell-side analysts predict that Avinger Inc will post -7.22 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Avinger (AVGR) Reaches New 1-Year Low at $0.27” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2018/11/10/avinger-avgr-reaches-new-1-year-low-at-0-27.html.

About Avinger (NASDAQ:AVGR)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Further Reading: How Do Tariffs Affect Trade Balances?

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.